Featured Post

Psychedelics Are Advancing in GAD, but None Are Yet Approved

July 16, 2026

Two psychedelics show early GAD trial signals—DT120 and psilocybin—but no agent is approved for anxiety. Interpreting evidence by stage, not label, matters
 Read More

Other top stories

Beyond SSRIs: Why the Next Advance in GAD May Not Target Monoamines

July 7, 2026

Generalized Anxiety Disorder: A Persistent Burden and a New Look at Psychedelics

July 7, 2026

Why Your Psychiatric Patients Aren’t Sleeping: CBT-I and a Pathway That Finally Works

March 30, 2026

The latest news on Depression (MDD)

Other stories

The Sleep Disorder You Are Missing in Your Psychiatric Patients & The Modern Solution For It

March 11, 2026

Brain Training Could Delay Dementia for Years

February 11, 2026

Psychosis Soars in Younger Generations

February 10, 2026

Ketogenic Diet Shows Modest Mental Health Benefits

February 9, 2026

Group Exercise Delivers Mental Health Gains

February 6, 2026

Weekly Mind Reader: Daylight Doesn’t Matter

February 6, 2026

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe